Myelofibrosis: A rare condition where progressive scarring or fibrosis of the bone marrow impairs it's ability to make blood cells causing symptoms such as anemia and liver and spleen enlargement. More detailed information about the symptoms, causes, and treatments of Myelofibrosis is available below.
See full list of 17 symptoms of Myelofibrosis
Review possible medical complications related to Myelofibrosis:
Book excerpts: Copyright © 2008 Lippincott Williams & Wilkins. All rights reserved.
Read more about causes of Myelofibrosis.
More information about causes of Myelofibrosis:
Rituxan is a monoclonal antibody therapy that was approved several years ago for specific types of non-Hodgkin's lymphoma . At the 2001 American...
Even "targeted" therapy for chronic myeloid leukemia is not without side effects. Some, like low blood counts, are serious. Hear how one patient,...
A routine check-up may find that you have too many white blood cells, a sign of leukemia. What can be done? Learn about leukemia and how new...
Targeted therapies—treatments that zero in on cancerous cells—are among the current treatments for fighting cancer. One type of targeted...
Prognosis for Myelofibrosis: slowly progressing disease resulting in death in 1-33 years
More about prognosis of Myelofibrosis
Visit our research pages for current research about Myelofibrosis treatments.
The US based website ClinicalTrials.gov lists information on both federally and privately supported clinical trials using human volunteers.
Some of the clinical trials listed on ClinicalTrials.gov for Myelofibrosis include:
See full list of 144 Clinical Trials for Myelofibrosis
Read about other experiences, ask a question about Myelofibrosis, or answer someone else's question, on our message boards:
A partial or complete replacement of the bone marrow stroma by fibrous tissue. It can be a primary bone marrow lesion as part of the chronic myeloproliferative disorders (chronic idiopathic myelofibrosis), a manifestation of acute myeloid leukemia (acute panmyelosis with myelofibrosis), or a secondary phenomenon due to bone marrow involvement by a metastatic tumor (e.g., metastatic breast carcinoma). --2003 - (Source - Diseases Database)
Fibrosis of the bone marrow - (Source - WordNet 2.1)
Myelofibrosis is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Myelofibrosis, or a subtype of Myelofibrosis,
affects less than 200,000 people in the US population.
Source - National Institutes of Health (NIH)
» Next page: What is Myelofibrosis?
What do you think about the features of this website? Take our user survey and have your say:
Next articles:
Tools & Services:
Medical Articles:
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
